TransMedics (TMDX) Amortization of Deferred Charges (2025 - 2026)
TransMedics' (TMDX) quarterly Amortization of Deferred Charges came in at $4.6 million in Q1 2026, up 483.61% year-on-year from $787000.0 in Q1 2025, and up 483.61% quarter-over-quarter from $787000.0 in Q1 2025.
TransMedics (TMDX) Amortization of Deferred Charges (2025 - 2026) Analysis & Trends
TransMedics' Amortization of Deferred Charges history runs 2 years deep, the most recent figure standing at $4.6 million for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.26 Bn | 175.96 Bn | 6.27 Bn |
| 2 | Stryker | 128.79 Bn | 125.92 Bn | 3.81 Bn |
| 3 | Medtronic | 108.56 Bn | 99.34 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.31 Bn | 66.86 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.27 Bn | 43.60 Bn | 1.29 Bn |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.12 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.40 Bn | 2.07 Bn |
| 10 | TransMedics | 2.50 Bn | 2.04 Bn | 101.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.59 Mn |
| Mar 31, 2026 | 4.59 Mn |
| Mar 31, 2025 | 787,000.00 |
| Mar 31, 2025 | 787,000.00 |